AI-based otitis media diagnostic solution ‘ECHO dot AI’ set for release: AIDOT leads innovation in on-device medical AI

AI-powered otitis media diagnostic system ‘ECHO dot AI’ | Image by AIDOT

AIDOT, a leading Korean company in on-device artificial intelligence (AI) medical devices, is preparing to launch its next innovation, the AI-based otitis media diagnostic system ‘ECHO dot AI.’

ECHO dot AI is a stand-alone device that operates without internet connectivity or additional security infrastructure. It can be reliably used at clinics, primary care institutions, and healthcare sites in both developed and developing countries regardless of network conditions, providing secure, immediate usability. The product is expected to offer a distinct advantage over conventional solutions in terms of accessibility, cost-effectiveness, and field applicability.

Its main feature is an AI diagnostic system that quickly and accurately analyzes the severity of otitis media (inflammation of the ear). The system recognizes the ear’s anatomical structure, identifies left and right ears, and precisely extracts the tympanic membrane area. It can capture images of the middle ear and simultaneously measure body temperature, enabling efficient management of a patient’s diagnosis and treatment history. External testing has verified the system’s high diagnostic performance, with sensitivity at 94.74%, specificity at 94.64%, and overall accuracy at 91.01%.

Professor Jaeho Jung of the Department of Otolaryngology at Hanyang University, who participated in the product’s development, said, “ECHO dot AI can be used without concerns about network or security, making it a breakthrough in improving medical access, cost, and usability in the field. Especially in the post-COVID-19 era, it holds great potential as a solution for quick and accurate diagnosis of otitis media in telemedicine, mobile clinics, and regional medical centers. I expect this new system, with its innovative diagnostics, accuracy, and user-friendly design, to transform the digital healthcare market both at home and abroad.”

He added, “Once deployed in the field, ECHO dot AI will be a true game-changer, elevating both clinical diagnostic capabilities and the treatment experience for patients. In scenarios involving mass patient occurrences like the COVID-19 pandemic, this device will offer immediate support to frontline medical professionals.”

ECHO dot AI is already attracting high interest from the medical community and industry ahead of its official launch. AIDOT plans to continue delivering innovative diagnostic solutions worldwide through its on-device AI medical technologies.

Founded in June 2014, AIDOT is a specialized medical AI development company. Starting with its AI-based cervical cancer screening system ‘Cerviray A.I.,’ the company has expanded its portfolio with the urinary stone diagnostic solution ‘URO dot AI,’ the gastrointestinal endoscopy AI systems ‘GIGA dot AI’ and ‘COLON dot AI,’ and now ‘ECHO dot AI’ for otitis media diagnostics. Its technologies are gaining global recognition through international commercialization.